Improved platform for breast cancer circulating tumor cell enrichment and characterization with next-generation sequencing technology.

No abstract is available for this paper.

• Publication year

  2023

• Venue

  American Journal of Cancer Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 36777514PMCID PMC9906071
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Better together: circulating tumor cell clustering in metastatic cancer

  2021cited by this paper
• Parathyroid Hormone‐Related Protein Inhibition Blocks Triple‐Negative Breast Cancer Expansion in Bone Through Epithelial to Mesenchymal Transition Reversal

  2021cited by this paper
• Circulating Tumor Cells (CTCs) Heterogeneity in Metastatic Breast Cancer: Different Approaches for Different Needs.

  2020cited by this paper
• Characterization of circulating breast cancer cells with tumorigenic and metastatic capacity

  2020cited by this paper
• Heterogeneity in Circulating Tumor Cells: The Relevance of the Stem-Cell Subset

  2019cited by this paper
• Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.

  2018cited by this paper
• Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting

  2018cited by this paper
• A conduit to metastasis: circulating tumor cell biology

  2017cited by this paper
• EMT, CSCs, and drug resistance: the mechanistic link and clinical implications

  2017cited by this paper
• Circulating tumor cell status monitors the treatment responses in breast cancer patients: a meta-analysis

  2017cited by this paper
• Detection of circulating tumor cells from cryopreserved human sarcoma peripheral blood mononuclear cells.

  2017cited by this paper
• Circulating tumour cells and pathological complete response: independent prognostic factors in inflammatory breast cancer in a pooled analysis of two multicentre phase II trials (BEVERLY-1 and -2) of neoadjuvant chemotherapy combined with bevacizumab

  2016cited by this paper
• Epithelial-to-mesenchymal transition leads to loss of EpCAM and different physical properties in circulating tumor cells from metastatic breast cancer

  2016cited by this paper
• Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound

  2015cited by this paper
• Circulating Tumor Cells After Neoadjuvant Chemotherapy in Stage I–III Triple-Negative Breast Cancer

  2015cited by this paper
• Circulating cancer stem cells: the importance to select.

  2015cited by this paper
• Expansion of CTCs from early stage lung cancer patients using a microfluidic co-culture model

  2014cited by this paper
• Circulating tumour cells—monitoring treatment response in prostate cancer

  2014cited by this paper
• Monitoring changes in circulating tumour cells as a prognostic indicator of overall survival and treatment response in patients with metastatic melanoma

  2014cited by this paper
• How Taxol/paclitaxel kills cancer cells

  2014cited by this paper
• Serial enumeration of circulating tumor cells predicts treatment response and prognosis in metastatic breast cancer: a prospective study in 393 patients

  2014cited by this paper
• Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors.

  2014cited by this paper
• CTC enumeration and characterization: moving toward personalized medicine.

  2014cited by this paper
• Liquid biopsy of gastric cancer patients: circulating tumor cells and cell-free nucleic acids.

  2014cited by this paper
• Circulating tumor cells and epithelial, mesenchymal and stemness markers: characterization of cell subpopulations.

  2014cited by this paper
• Circulating Tumor Cells in Prostate Cancer

  2013cited by this paper
• Guidelines on the Use of Therapeutic Apheresis in Clinical Practice—Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Sixth Special Issue

  2013cited by this paper
• Adverse events associated with apheresis procedures: Incidence and relative frequency

  2013cited by this paper
• Circulating tumor cells

  2013cited by this paper
• Circulating tumor cell (CTC) count and epithelial growth factor receptor expression on CTCs as biomarkers for cetuximab efficacy in advanced colorectal cancer.

  2013cited by this paper
• EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like, and HER2 intrinsic subtypes of breast cancer

  2013cited by this paper
• Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay

  2013cited by this paper
• Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients

  2013cited by this paper
• Circulating Tumor Cells: The Substrate of Personalized Medicine?

  2012cited by this paper
• Detection of circulating tumor cells in cancers of biliary origin.

  2012cited by this paper
• Circulating tumour cells in non-metastatic breast cancer: a prospective study.

  2012cited by this paper
• Changes in Keratin Expression during Metastatic Progression of Breast Cancer: Impact on the Detection of Circulating Tumor Cells

  2012cited by this paper
• Circulating tumor cells: a useful predictor of treatment efficacy in metastatic breast cancer.

  2009cited by this paper
• Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

  2008cited by this paper
• Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer.

  2008cited by this paper
• Detection of Circulating Tumor Cells in Peripheral Blood of Patients with Metastatic Breast Cancer: A Validation Study of the CellSearch System

  2007cited by this paper
• In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells.

  2003cited by this paper
• Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breast cancer treated with high-dose chemotherapy and stem cell transplantation

  2001cited by this paper

• Isolation and typing techniques for circulating tumor cells

  2026cites this paper
• Detection of Cancer Stem Cells from Patient Samples

  2025cites this paper
• A method for identifying neoantigens through isolation of circulating tumor cells using apheresis among patients with advanced-stage cancer

  2025cites this paper
• Clinical applications of circulating tumor cells in metastasis and therapy

  2025cites this paper
• Circulating Tumor Cell‐Derived Organoids: Current Progress, Applications, and Future

  2025cites this paper
• Development and evaluation of CD45-conjugated magnetic particles-based host cell depletion for enhanced metagenomic next-generation sequencing in bloodstream infection.

  2025cites this paper
• Liquid Biopsy in the Clinical Management of Cancers

  2024cites this paper
• TNFSF12 is associated with breast cancer prognosis and immune cell infiltration.

  2024cites this paper